Timothy Mark Dyer insider trades
Open-market stock purchases and sales by Timothy Mark Dyer, CHIEF EXECUTIVE OFFICER at Addex Therapeutics Ltd, from SEC Form 4 filings since Sep 2, 2026.
Companies traded
- ADXN Addex Therapeutics Ltd: other filings, last Sep 2, 2026